Synapse Medicine at Himss 22

Synapse Medicine will be attending Himss 22 in Orlando. Contact us now to schedule a meeting!

About Synapse Medicine

About Synapse Medicine

Discover how Synapse Medicine facilitates medication reconciliation, pharmacovigilance, and prescription safety with its Medication Intelligence platform.

Dates

Dates

14th-18th March 2022

Event Location

Event Location

Innovation Live Area at Orange County Convention Center

Our Team at Himss 22

Our Team at Himss 22

Clement Goehrs, Iris Pujade, Franck Tricot, Nadjib Bennaï, Benoit Egarnes, Amandine Caekaert

Contact information

ANSM
CHU Bordeaux
MACSF
Thériaque
Hôpital Georges Pompidou

Improving patient safety with Synapse Platform

Synapse Platform transforms care by enabling healthcare professionals and the general public access to the best medicine.

Powered by Medication Intelligence

Powered by Medication Intelligence

Synapse Platform’s Medication Intelligence technology provides a comprehensive overview of drug-related information to facilitate medical decision-making.

A Suite of Solutions

A Suite of Solutions

Synapse Platform solutions are serving telemedicine technologies, hospitals, insurances, and software companies to secure every step of the healthcare journey.

Facilitating Medication Reconciliation

Facilitating Medication Reconciliation

Synapse Medicine's medication reconciliation digital solution helps optimizing the med rec process and preventing medication errors.

Automating Pharmacovigilance

Automating Pharmacovigilance

Synapse Medicine's pharmacovigilance technology named "Medication Shield" facilitates the management of adverse event reports.

+50 Partnerships Worldwide

+50 Partnerships Worldwide

Synapse Medicine operates in 7 countries such as USA, France, UK, Japan, Germany, Italy, Spain.

3 COVID-19 Initiatives

3 COVID-19 Initiatives

Synapse Medicine developed 3 COVID-19 initiatives that help make a difference since the beginning of the pandemic. Its Medication Shield technology currently automates the pharmacovigilance of the COVID-19 vaccination campaign in France and won the Prix Galien award in December 2021.

Logo Co-founder and CEO of Synapse Medicine

Clement Goehrs

Co-founder and CEO of Synapse Medicine

“As the European leader in medication reconciliation, we are pleased to participate in Himss 22. It is a great opportunity for us to present our digital solutions that improve patient safety ”

Get in touch with Dr. Clement Goehrs: Linkedin